These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3350991)

  • 21. Effect of lasofoxifene on the pharmacokinetics of digoxin in healthy postmenopausal women.
    Roman D; Bramson C; Ouellet D; Randinitis E; Gardner M
    J Clin Pharmacol; 2005 Dec; 45(12):1407-12. PubMed ID: 16291716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist.
    Denker AE; Morelli G; Vessey LK; Li S; Yuan J; Dunbar S; Lewis NM; Taggart W; Wagner JA
    Adv Ther; 2009 Feb; 26(2):230-40. PubMed ID: 19219408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of pharmacokinetic interactions between moxonidine and digoxin.
    Pabst G; Weimann HJ; Weber W
    Clin Pharmacokinet; 1992 Dec; 23(6):477-81. PubMed ID: 1458765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cibenzoline after single and repetitive dosing in healthy volunteers.
    Massarella JW; Khoo KC; Szuna AJ; Sandor DA; Morganroth J; Aogaichi K
    J Clin Pharmacol; 1986 Feb; 26(2):125-30. PubMed ID: 3950056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of multiple doses of montelukast, a CysLT1 receptor antagonist, on digoxin pharmacokinetics in healthy volunteers.
    Depré M; Van Hecken A; Verbesselt R; Wynants K; De Lepeleire I; Freeman A; Holland S; Shahane A; Gertz B; De Schepper PJ
    J Clin Pharmacol; 1999 Sep; 39(9):941-4. PubMed ID: 10471986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance.
    Meeus R; Verpooten GA; De Paep R; Paelinck BP; Neels H; Cooreman S; De Doncker M; Jorens PG
    Clin Toxicol (Phila); 2008 Apr; 46(4):303-6. PubMed ID: 18363124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of troglitazone on steady-state pharmacokinetics of digoxin.
    Loi CM; Knowlton PW; Stern R; Randinitis EJ; Vassos AB; Koup JR; Sedman AJ
    J Clin Pharmacol; 1998 Feb; 38(2):178-83. PubMed ID: 9549650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
    De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G
    Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects.
    Feuring M; Lee Y; Orlowski LH; Michiels N; De Smet M; Majumdar AK; Petty KJ; Goldberg MR; Murphy MG; Gottesdiener KM; Hesney M; Brackett LE; Wehling M
    J Clin Pharmacol; 2003 Aug; 43(8):912-7. PubMed ID: 12953348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.
    Hausner H; Derving Karsbøl J; Holst AG; Jacobsen JB; Wagner FD; Golor G; Anderson TW
    Clin Pharmacokinet; 2017 Nov; 56(11):1391-1401. PubMed ID: 28349387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the pharmacokinetic interaction between zileuton and digoxin in humans.
    Awni WM; Hussein Z; Cavanaugh JH; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():92-7. PubMed ID: 8620677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of time of dosing on the disposition of oral cibenzoline.
    Brazzell RK; Khoo KC; Schneck DW
    Biopharm Drug Dispos; 1985; 6(4):433-40. PubMed ID: 4084668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers.
    Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK
    Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
    Touboul P; Atallah G; Kirkorian G; de Zuloaga C; Dufour A; Aymard MF; Lavaud P; Moleur P
    Am Heart J; 1986 Aug; 112(2):333-9. PubMed ID: 3526853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
    Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (Lanoxin) in normal healthy subjects: a placebo-controlled evaluation.
    Miyazawa Y; Paul Starkey L; Forrest A; Schentag JJ; Kamimura H; Swarz H; Ito Y
    J Clin Pharm Ther; 2002 Feb; 27(1):13-9. PubMed ID: 11846858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the steady-state pharmacokinetics of digoxin in healthy adult subjects.
    Liu F; Vessey L; Wenning L; Connolly S; Buckland M; Johnson-Levonas AO; Denker A; Wagner JA; Lai E
    J Clin Pharmacol; 2010 Jul; 50(7):823-8. PubMed ID: 20197486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of a new antiarrhythmic agent: cibenzoline.
    Rigaud M; Jouret G; Canal M; Bardet J; Flouvat B; Bourdarias JP
    J Pharmacol; 1985; 16(3):247-57. PubMed ID: 4068726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac electrophysiological effects of cibenzoline in the conscious dog: plasma concentration-response relationships.
    Boucher M; Dubray C; Kantelip JP; Talmant JM; Dufour A; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1989 Oct; 14(4):616-21. PubMed ID: 2478775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dofetilide on the pharmacokinetics of digoxin.
    Kleinermans D; Nichols DJ; Dalrymple I
    Am J Cardiol; 2001 Jan; 87(2):248-50, A9-10. PubMed ID: 11152855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.